We are advised by Jiangsu Vcare that journalists and other readers should disregard the news release, Jiangsu Vcare Files NDA for Vicagrel Capsules with US FDA, issued 04-Jan-2024 over PR Newswire.

Source link

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
You May Also Like

U.S. Immigration Fund Welcomes Emily Zhu as Vice President of Business Development, Head of East Asia

PALM BEACH, Fla., May 1, 2025 /PRNewswire/ — U.S. Immigration Fund (USIF),…

CGTN: Second China-Central Asia Summit eyes a closer China-Central Asia community with a shared future

BEIJING, June 14, 2025 /PRNewswire/ — Following the announcement by China’s Foreign…

New Executive Management Board at Bender – the world's leading provider of solutions that make electrical infrastructures smart and safer

GRÜNBERG, Germany, May 8, 2025 /PRNewswire/ — Bender Industries GmbH & Co.…